Licensing & Corporate Partnering
“Thar’s Gold in Them Thar Hills” – Prospecting New Sources of Capital and Partnerships for Clinical-Stage Companies in China
U.S. biotech/pharma companies often focus their efforts and attention in the United States, which makes perfect sense as international operations increase costs and complexities. And the U.S. is the largest market in…
